Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Stephan Seiffert
Introduction
Stephan Seiffert is a notable inventor based in Kulmbach, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the detection of oligonucleotides. His work has implications for various applications, including genetic research and diagnostics.
Latest Patents
Stephan Seiffert holds 1 patent for an innovative method related to oligonucleotide detection. The patent describes a method that utilizes anion exchange high-performance liquid chromatography for the detection of oligonucleotides. This method involves hybridizing fluorescently labeled peptide nucleic acid oligomers, which are complementary to the oligonucleotides. Following this, anion exchange high-performance liquid chromatography is performed to detect and quantify the hybridized moieties. Additionally, the invention includes a method for the simultaneous detection of both strands of an oligonucleotide from a single sample, along with a kit designed for qualitative and quantitative detection of one or two strands of an oligonucleotide.
Career Highlights
Stephan Seiffert is currently associated with Axolabs GmbH, where he continues to advance his research and development efforts. His expertise in oligonucleotide detection has positioned him as a valuable asset in the biotechnology sector.
Collaborations
Stephan has collaborated with notable colleagues, including Ingo Roehl and Markus Schuster. Their combined efforts contribute to the innovative environment at Axolabs GmbH.
Conclusion
Stephan Seiffert's work in oligonucleotide detection exemplifies the intersection of innovation and biotechnology. His contributions are paving the way for advancements in genetic research and diagnostics.